Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

The market faces challenges such as high costs of sophisticated devices and rural preference for traditional methods, but ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

Opinion - In South Africa, two people can live with the same chronic condition yet face vastly different realities.

In Nigeria, a silent health crisis is unfolding—diabetes, once thought to be an adult disease, is increasingly affecting ...

As local advocates work to create a syringe exchange program in Evansville, the framework for the whole system is up in the ...

Learn about the new California laws addressing pet rescue, transgender ID changes, and sterile syringes for disease ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

On Monday Gov. Gavin Newsom decided the fate of the remaining bills lawmakers sent to his desk in September. Throughout this legislative session, a total of 917 bills awaited the governor’s verdict, ...